Péron, J., Roy, P., Conroy, T., Desseigne, F., Ychou, M., Gourgou-Bourgade, S., . . . Buyse, M. (2016). An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget.
Chicago Style aipamenaPéron, Julien, et al. "An Assessment of the Benefit-risk Balance of FOLFIRINOX in Metastatic Pancreatic Adenocarcinoma." Oncotarget 2016.
MLA aipamenaPéron, Julien, et al. "An Assessment of the Benefit-risk Balance of FOLFIRINOX in Metastatic Pancreatic Adenocarcinoma." Oncotarget 2016.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.